3,116
Participants
Start Date
September 30, 2010
Primary Completion Date
March 31, 2011
Study Completion Date
September 30, 2011
TIV
Investigational egg-derived trivalent subunit influenza vaccine.
TIVf
US licensed trivalent inactivated subunit influenza vaccine -Fluvirin (Novartis Vaccines and Diagnostics) is approved for use in subjects ≥4 years.
Comparator TIV
US licensed trivalent subunit inactivated influenza vaccine- Fluzone (Sanofi Pasteur) is approved for use in children \<4 years.
Philippine General Hospital, Taft Avenue, Manila
Mary Chiles General Hospital, 667 Gastambide St. Sampaloc, Manila
University of the East Ramon Magsaysay Medical Center, 64 Aurora Boulevard, Barangay Dona Imelda Quezon City
Research Institute for Tropical Medicine, Department of Health Compound, Filinvest Corporate City, Alabang
Research Institute for Tropical Medicine, Department of Health Compound, FILINVEST Corporate City, Alabang, Muntinlupa City
De La Salle Health Sciences Institute, Dasmarinas Cavite
Centro de Atención e Investigación Medica - CAIMED, Carrera 42A # 17-50, Bogotá
Clinical research institute ,S.C(CRI), Blvd Manuel Avila Camacho 1994 Consultorio 1103 Col. San Lucas Tepetlacalco, C.P.54055 Tlalnepantla, Estado de México
Centro de Salud Magally Ruiz, Street Bolivar, Panama - La Chorrera
Clinica Hospital San Fernando, Floor 4 Office 419 via España las Sabanas, Panama City
Consultorios America Floor 2 Office 201-1, Via España Vista Hermosa, Panama City
Consultorios Medicos San Judas Tadeo Principal Street, Floor 5 Office 507, Villa Lucre, Panama City
Philippine Children's Medical Center, Quezon Avenue corner Agham Road, Quezon City
Lead Sponsor
Novartis Vaccines
INDUSTRY